In a groundbreaking move towards modernising healthcare, England's National Health Service (NHS) has successfully implemented digital prescriptions,
as reported by the World Health Organization (WHO) in its latest regional digital health report.
Since January 2024, patients across England have had access to their prescription information through the NHS App, marking a significant leap in healthcare
accessibility and efficiency.
With over 33 million registered users, representing 75 per cent of the adult population, the NHS App has become a vital tool in managing healthcare online.
The introduction of digital prescriptions allows users to order repeat prescriptions online without the need for a GP visit.
This innovation has witnessed a surge in digital requests, with over 3.1 million repeat prescriptions processed monthly.
Authorities in Northern Ireland have seized more than 242,000 unlicensed prescription tablets purchased online and destined for addresses throughout NI.
The medicines seized include Diazepam, used for anti-anxiety treatment, Pregabalin, used for epilepsy and anxiety, steroids and Zopiclone.
Other prescription medicines recovered included Tamoxifen, often used in the treatment of breast cancer and Salbutamol inhalers, frequently used in the treatment
of asthma.
"Co-operation between law enforcement agencies and government departments has led to the seizure of over 242,000 illegal and unlicensed tablets purchased online
and destined for addresses throughout Northern Ireland," justice minister Naomi Long was reported as saying.
The minister, together with health minister Robin Swann and assistant chief constable Mark McEwan PSNI were highlighting Northern Ireland's input to the global,
Interpol co-ordinated Operation Pangea XV, which saw multiple packages of tablets intercepted and seized, with a street value of almost £250,000.
She praised the concerted efforts made by PSNI, Border Force and officials from the Department of Health Medicines Regulatory Group during a specific week of action
in June.
Boots has become the first community pharmacy in the UK to transport prescription medicines by a drone.
The pharmacy multiple completed a test flight transporting prescription-only medicines by drone from Portsmouth to the Isle of Wight earlier this month.
The flight departed from the British Army's Baker Barracks on Thorney Island near Portsmouth and arrived at St. Mary's Hospital on the Isle of Wight. The medicines
were collected by Boots personnel and transported to the multiple's pharmacies across the island, where they will be dispensed to patients with prescriptions for them.
Boots worked with medical drone start-up Apian to facilitate the test flight and is now assessing the future potential for drones in medicines delivery.
Rich Corbridge, chief information officer at Boots, said: "Drones have a huge potential in the delivery of medicines and it is incredibly exciting to be the first
community pharmacy in the UK to transport them in this way. An island location like the Isle of Wight seemed like a sensible place to start a trial of drones and
their value to the delivery of medicines to more remote locations is very clear.
To lead the way in modernizing the UK's healthcare, the National Health Service (NHS) digitized the prescriptions. WHO mentioned this in their current
digital regional report. Since January 2024, the NHS App in England has offered patients the opportunity to see statistics about their prescriptions.
This represents a gigantic step in the area of healthcare which can be categorized as another stage in healthcare accessibility and efficiency. Over 33 million
residents have taken the NHS app enabling the users to be 75% of the adult population. The app helps in online management of their health. The use of digital
prescriptions enables patients to order repeated prescriptions online, in which they would past getting an appointment a GP.
Data crunched by an online pharmacy delivery company paints a concerning picture for the pharmacy sector in England.
Gophr's 'Prescription For Pressure' initiative reveals a challenging time for the sector and is supported by separate analysis by the BBC showing that the number
of pharmacies in England is at its lowest since 2010.
In addition, new powers being introduced for pharmacists to prescribe common prescription drugs and perform routine tests create an even greater workload for already
overstretched pharmacists.
Gophr's data reveals that:
* Each pharmacy in England serves an average of 6,078 people.
* In 2022, pharmacists dispensed 1.043 billion prescriptions, 26.3 million more than 2021.
* A single pharmacy in England dispensed 248 prescriptions a day on average in 2022.
Based on the most up-to-date statistics from the Office for National Statistics, NHS England and Statista, Gophr's calculations show that pharmacists have around 116
seconds to dispense a prescription, which is less time than the 180 seconds it takes to make a Quarter Pounder at McDonald's.
Online pharmacy delivery partner Gophr has released new data showing a further drop in pharmacy numbers in England, resulting in a phenomenon they
call 'Pharmacy Deserts'.
Gophr highlighted that a significant portion of the population now lives in 'pharmacy deserts,' referring to the situation where an increasing number of urban
residents struggle to access a shrinking number of pharmacies.
For the second consecutive year, Gophr has analysed the data for its 'Prescription For Pressure' initiative.
The analysis showed that in 2023, pharmacists dispensed 1.18 billion prescriptions across England, marking an increase of 137 million compared to 2022.
The average number of prescriptions per pharmacy stands at 103,380, which equates to 283 a day.
As calculated by Gophr's data experts, pharmacy numbers decreased from 11,522 in 2022 to 11,414 in 2023, reflecting a decline of 108 compared to the previous
year's 'Prescription For Pressure'.
Gophr's data also showed that pharmacy deserts are most prominent in the South East (6,024 people per pharmacy), the East of England (5,327), the South West
(5,284), and the Midlands (4,975).
London, which ranked high last year, fell out of the top four, with 4,759 people per pharmacy.
Department of Health and Social Care (DHSC) has issued a supply notification for Varicella vaccine (live) powder and solvent for suspension/solution for
injection 0.5ml vials (Varivax and Varilrix) until mid-October.
AAH have put quotas in place for GPs to limit the ordering of Varilrix and safeguard supplies during this shortage. To override this quota or obtain stock in any
other primary care setting (including community pharmacy) a prescription will be required.
To obtain stock through the prescription validation system pharmacy will have to contact AAH Quota Management Customer Care team:
Online https://www.aah.co.uk/s/quotarequest or by logging into AAH Point https://www.aah.co.uk/s/signin then choose Additional Services and select Quotas.
The pharmacy should follow the steps and fill in the required information including their email address.
The pharmacy can also call: 0344 561 8899 and select option 3 (quota)
The pharmacy will need to have the prescription details available
The AAH team will review the request and follow the guidance provided below to validate the prescription and approve the order.
A BBC investigation has found 20 UK online pharmacies selling prescription-only medicines without adhering to the regulatory standards, such as checking
for GP approval or patient's medical records.
The news organisation was able to purchase over 1,600 restricted pills, including anti-anxiety drug, painkiller and sleeping medication, from these regulated
online pharmacies easily by providing false information.
However, the report didn't mention the names of the drugs as "they can be dangerous when taken without medical guidance."
Some pharmacies were also found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires
and did not require further checks.
The General Pharmaceutical Council (GPhC), which regulate online pharmacies in the UK, states that selling and supplying medicines at a distance brings
"different risks which need to be appropriately managed to protect patient safety."
The Medicines and Healthcare products Regulatory Agency (MHRA) has maintained the prescription-only status of Aquiette 2.5mg Tablets for symptoms of
overactive bladder, following a public consultation and the review of a reclassification application from the manufacturer Maxwellia Ltd.
Aquiette, which contains the active ingredient oxybutynin, is used for the treatment of long-term symptoms of overactive bladder (OAB) in women aged between 18
and 65, such as the urgent need to urinate and frequent urination without pain.
The regulator decided against the reclassification of Aquiette 2.5mg Tablets from a prescription-only medicine (POM) to a pharmacy (P) medicine, concluding that
a medical prescription continues to be required to ensure the safe use of Aquiette.
Since an OAB diagnosis requires medical supervision to ensure that the correct treatment is received, and other health conditions are not overlooked or left untreated,
the MHRA said the decision would ensure that the medication is used safely and appropriately under medical supervision.
"After taking on board the views of the many patients and healthcare professionals who responded, we have decided to refuse the reclassification of Aquiette 2.5mg
Tablets for women with symptoms of overactive bladder (OAB)," Dr Laura Squire, MHRA chief healthcare quality and access officer, said.
"Our main concerns are that the use of what they call an asynchronous supply, where the prescriber neither sees nor talks to the patient at the time they
issue the prescription, does lay itself open to perhaps people getting hold of medication that they shouldn't," the Head of Policy, PDA said.
The Pharmacists' Defence Association (PDA) engages in a critical conversation on BBC Radio 4's Woman's Hour, shedding light on the online prescribing of weight
loss drugs and advocating for safer practices.
The PDA's spokesperson, Head of Policy Alima Batchelor, emphasised the importance of adhering to professional guidelines to ensure patient safety and mitigate
regulatory concerns.
During the feature, the PDA highlighted the complexities and risks associated with online supply chains, stressing the necessity for direct clinical consultations
and pharmacist involvement in medication management.
""There are guidelines and advice about verification within the DiCE guidance, but it doesn't go quite far enough for us. We are concerned when patients decline
to allow the online prescriber to advise their GP of what they're taking," Batchelor highlighted.
Buy Votrient 200 Mg Pazopanib Hydrochloride Tablets India-Russia , Votrient-200Mg is not a chemotherapy drug but one of many "targeted therapies." Targeted therapy is the result of about 100 years of research dedicated to understanding the differences between cancer cells and normal cells.
We are leading suppliers & exporters of "Votrient 200Mg" in China, Russia, Hongkong, Bulgaria, Romania, India, UK, USA. We're largest suppliers of Glaxo Smith Kline medicines & provide you the best price on Votrient.
The lowest price sellers, suppliers, distributors & Exporters from Delhi. For more info please contact us.
Buy Votrient 200 Mg Pazopanib Hydrochloride Tablets India
Votrient 200Mg Suppliers India
Pazopanib is used to treat kidney cancer. It may also be used to treat certain other types of cancer (soft tissue sarcoma). Pazopanib belongs to a class of drugs known as Tyrosine Kinase Inhibitors. It works by decreasing the blood supply to the cancer tumor to slow tumor growth.
VOTRIENT may shrink or slow the growth of the cancer by interfering with the function of a protein called vascular endothelial growth factor. It is used to treat adults with metastatic renal cell carcinoma, a form of kidney cancer.. Itmay shrink or slow the growth of kidney cancer for a period of time.
we are leading suppliers & exporters of Votrient 200Mg Pazopanib Hydrochloride Tablet in China, Russia, Hongkong, Bulgaria, Romania, India, UK, USA and many more
And the largest suppliers-exporters of "Glaxo smith Kline" medicines & provide you the best price on Votrient 200Mg Pazopanib Hydrochloride Tablet.
The lowest price sellers, suppliers, distributors & Exporters from Delhi For More Info Please Contact us.
Brand Name - Votrient
Generic - Pazopanib Hydrochloride
Strength - 200 Mg
Form - Tablets
Packing - 1 X 30
Manufactured by - Glaxo smith Kline
Warning: Votrient 200Mg medicine out of the reach and sight of children and away from pets, never share your medic
People in the UK have a high level of trust in pharmacies and many are keen on seeing the Pharmacy First initiative expanded, according to the 2024 STADA
Health Report published today (24 June).
The 10th annual health report by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, involved a survey of over 46,000
respondents across 23 countries, including 2,000 participants from the UK.
The UK data showed an overwhelming trust in UK pharmacies, with 94 per cent of those surveyed (more than nine out of 10 Brits) saying they have only ever had
good advice from a pharmacist.
The report also indicated a strong desire for the Pharmacy First scheme to be expanded, with 44 per cent of respondents advocating for an increase in pharmacists'
scope of responsibilities to support doctors.
Atorvastatin, a medicine to treat high blood cholesterol, is the most dispensed drug with 59 million items in England in 2022/23, revealed the NHS Business
Services Authority (NHSBSA) on Thursday (8 June).
While Apixaban (an anticoagulant) was the drug with the highest costs of £430 million. Apixaban 5mg tablets had the largest increase in cost between 2021/22 and
2022/23 in England, with an increase of £280 million.
NHSBSA's annual statistics report 'Prescription Cost Analysis-England 2022/23' published also has revealed an eight per cent rise in the prescription items that
were dispensed in the community in England.
The report highlighted that in 2022/23, 1.18 billion prescription items were dispensed at a cost of £10.4 billion in the community in England, witnessing an
increase of eight per cent from £9.69 billion in 2021/22.
Online pharmacy PillTime has taken a step to boost its prescription growth by implementing new Patient Medication Record (PMR) system Titan in its
state-of-the-art premises.
PillTime moved to new, expanded 26,000sqft premises in Cribbs Causeway on the edge of Bristol earlier this year, where it has also installed state-of-the-art
robotics in a bid to significantly enhance future productivity and capacity.
Teething problems over Easter weekend saw PillTime struggling to seamlessly integrate all the new systems and processes while physically moving premises which
affected service delivery and customer support.
However, CEO Leighton Humphreys was supported by Tariq Muhammad, CEO of Invatech Health, who is a former community pharmacist and has worked with independent
pharmacies around the UK as well as larger online businesses, to integrate Titan into their workflows.
Alongside integration work, Muhammad and his team supported PillTime with necessary design, governance and pharmacy expertise as the company struggled to meet its
usual high standards for dispensing medicines to patients.
A drug dealer who was operating as an "unlicensed chemist" and selling prescription drugs online has been jailed for six years, according to Essex Police.
The convict, identified as 49-year-old Christopher Depp, aka David Jones, was supplying a range of drugs from his home to "vulnerable people" using the postal
service, local police revealed on Friday (February 16).
Police conducted a search operation at his address in Wood Street, Chelmsford, in July last year and found more than 50,000 pills and tablets of varying types,
stashed in toolboxes and spaces around the property.
To process the large-scale sale and shipping of controlled drugs across the UK, Depp had set up a room in his property as an office space.
He promoted the sale of medications through various social media platforms and messaging applications, and accepted payment from his large customer base
using "fraudulently obtained" bank accounts.
Buy Online Sorafenat 200mg tablet price in India, Sorafenat is a malignancy (chemotherapeutic) prescription.
Sorafenat, made by Natco, contains Sorafenib Tosylate as dynamic fixing.
It is a medicine oncology tranquilize that ought to be utilized underappropriate restorative direction and guidance.
We are leading suppliers & exporters of "Sorafenat 200Mg" in China, Russia, Hongkong, Bulgaria, Romania, India, Uk, USA. We're largest suppliers of Natco medicines & provide you the best price on Soafenat.
The lowest price sellers, suppliers, distributors & Exporters from Delhi. For more info please contact us
Buy Sorafenat 200Mg Tablet Suppliers Price in India
sorafenat-tablets-suppliers-india
Sorafenat 200Mg Tablets
Product Description:
Brand Name: Sorafenat
Generic Name: Sorafenib
Strength: 200mg
Package: Pack of 60 & 120 Tablets
Form: Tablets
Manufactured by: Natco Pharma Ltd
The Doctor's mostly prescribed Drug "Sorafenat 200Mg Tablet" twice in a day. It should be taken a couple of hours before taking your meal. You can gulp Sorafenat 200Mg Tablet down with the help of normal water, but be ensure you take it whole. Don't crush or break the tablet. Go for your regular blood pressure checks, when you are taking Sorafenat 200Mg Tablet. When it comes to storage of this drug, do not let it come in contact with heat or moisture.
Try not to convey the pharmaceutical to others, since they might experience the ill effects of an issue that is not adequately treated by this medication.
Sorafenat is an effective drug for treatment of cancer disease, The Sorafenat 200Mg Tablet is responsible for preventing , development & multiplication of cancer cells. And that is why this drug could be used in the treatment of the patients suffering from thyroid cancer, liver cancer or as well as renal cancer.
Buy Online Sorafenat 200 Mg Tablet Exporters Price India
sorafenat 200mg Suppliers price India
We are very thankful to come on this website "Sorafenat 200Mg S
Presently, In the US, around 12% of women develop breast cancer over the course of their lifetime. In Canada, an estimated 26,900 women were expected to be diagnosed with breast cancer in 2019 and breast cancer accounts for nearly 25% of new cases of cancer among Canadian women. Download complete report summary @
http://bit.ly/2vsEa1D
Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities
will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement.
The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality
for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff.
According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by
LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place
at 128,691 items.
Jhoots Group, a West Midlands based independent community pharmacy chain, has unveiled plans to expand its digital services after securing a funding worth
£8.23m from HSBC bank.
The new money will allow the groups branches to offer a digital platform for customers to request prescriptions online, enabling the implementation of a hub and
spoke dispensing system to automate prescription deliveries.
The innovation aims to reduce the burden of manual processes on pharmacists, allowing staff to use their time efficiently and support the NHS by offering vaccines
and minor ailment medicine services.
San Jhooty, chief operating officer at Jhoots Group, said: "When faced with the unprecedented challenges of the pandemic, primary and community services came
together to support the community and each other.
Within the last few weeks, at least six pharmacists have been subjected to interim order applications - either suspended or had significant restrictions
placed upon their registration pending a full 'Fitness to Practise' hearing into serious allegations being made about their prescribing practices, the Pharmacists'
Defence Association (PDA) has found.
It said that there has been a "dramatic increase in action being taken by the pharmacy regulator (GPhC) against pharmacist prescribers associated with certain types
of online prescribing services".
It has warned pharmacist prescribers who work for online pharmacies about the specific risks associated with remote prescribing using a questionnaire-based model,
typically with no direct prescriber/patient interaction.
Common features that underpin the allegations include the following: Overreliance on a patient questionnaire to inform clinical decision making; No patient/prescriber
interaction; Prescribing high risk medicines without adequate safeguards; Inadequate systems and processes leading to inappropriate prescribing; Very high volumes
of prescriptions being authorised in short periods of time; and Prescribers/patient relationship established via an unregulated online portal.
Growing up with a family that worked in pharmacy, our dinner time conversation was not like that of other families. Ours would centre around medicines,
prescriptions, and the health challenges within our local community.
I quickly came to understand the importance of the role played by community pharmacists. So I can't help but be concerned that the current direction being taken by
digital health innovation threatens to leave community pharmacies behind.
Whilst it is brilliant that patients can easily access their prescriptions through the rise of online pharmacies, many of these cut out the vital knowledge and
expertise of local community pharmacists, and threaten to end the traditional close ties between local community pharmacists and their patients.
Nine out of 10 NHS users believe that pharmacists play an unrivalled role when it comes to keeping patients in the community safe. We must ensure that digital health
does not replace this important source of advice for health problems and injuries, but instead preserves and enhances this vital, personal role and enables
pharmacists to continue delivering care in new and effective ways.
A vital connection with patients
Community pharmacies provide crucial support to local patients with managing their medicines safely, particularly older and more vulnerable people. The specific
expertise and knowledge held by pharmacists can help inform the long-term management of a patient's condition and ensure they are kept safe from potential side
effects and complications.